T1	PROC 44 53	Protocolo
#1	AnnotatorNotes T1	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T2	LIVB 81 90	pacientes
#2	AnnotatorNotes T2	C0030705; Patients; Patient or Disabled Group
T3	DISO 95 148	adenocarcinoma gástrico o de la unión gastroesofágica
T4	Neg_cue 169 171	no
T5	Negated 172 181	resecable
T6	DISO 184 195	metastásico
#3	AnnotatorNotes T6	C4255448; Metastasis; Pathologic Function
T7	PROC 217 275	Protocolo abierto, multifármaco, multicéntrico, de fase II
T8	PROC 281 361	evaluar la eficacia, seguridad, tolerabilidad, farmacocinética e inmunogenicidad
T9	LIVB 389 398	pacientes
#4	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 403 444	adenocarcinoma gástrico o gastroesofágico
T11	Neg_cue 465 467	no
T12	Negated 468 477	resecable
T13	DISO 480 491	metastásico
#5	AnnotatorNotes T13	C4255448; Metastasis; Pathologic Function
T14	DISO 532 577	cáncer gástrico o de la unión gastroesofágica
T15	Neg_cue 582 584	no
T16	PROC 594 602	extirpar
#6	AnnotatorNotes T16	C0728940; Excision; Therapeutic or Preventive Procedure
T17	Negated 594 602	extirpar
T18	PROC 612 619	cirugía
#7	AnnotatorNotes T18	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T19	Negated 612 619	cirugía
T20	DISO 645 687	Adenocarcinoma de la unión gastroesofágica
#8	AnnotatorNotes T20	C1332166; Adenocarcinoma of the gastroesophageal junction; Neoplastic Process
T21	Neg_cue 708 710	no
T22	Negated 711 720	resecable
T23	DISO 723 734	metastásico
#9	AnnotatorNotes T23	C4255448; Metastasis; Pathologic Function
T24	Age 763 776	18 años o más
T25	PROC 811 824	Peso corporal
T26	Neg_cue 836 838	No
T27	PROC 845 852	tratado
T28	Negated 845 852	tratado
T29	DISO 873 926	adenocarcinoma gástrico o de la unión gastroesofágica
T30	Negated 897 898	o
T31	Negated 911 926	gastroesofágica
T32	Neg_cue 927 929	no
T33	Negated 930 939	resecable
T34	DISO 942 953	metastásico
#10	AnnotatorNotes T34	C4255448; Metastasis; Pathologic Function
T35	DISO 967 987	lesión diana medible
T36	LIVB 1004 1016	investigador
#11	AnnotatorNotes T36	C0035173; Research Personnel; Professional or Occupational Group
T37	Duration 1079 1098	al menos 12 semanas
T38	ANAT 1122 1129	órganos
#12	AnnotatorNotes T38	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T39	ANAT 1132 1143	médula ósea
#13	AnnotatorNotes T39	C0005953; Bone Marrow; Tissue
T40	LIVB 1173 1186	Participantes
T41	PROC 1191 1195	HER2
T42	DISO 1213 1216	IHC
#14	AnnotatorNotes T42	C2936476; Chronic Liver Failure; Disease or Syndrome
T43	DISO 1227 1230	IHC
#15	AnnotatorNotes T43	C2936476; Chronic Liver Failure; Disease or Syndrome
T44	PROC 1246 1249	ISH
T45	DISO 1253 1271	carcinoma gástrico
#16	AnnotatorNotes T45	C0699791; Stomach Carcinoma; Neoplastic Process
T46	DISO 1274 1291	GEJ indeterminado
T47	DISO 1295 1325	Enfermedad metastásica del SNC
T48	Neg_cue 1339 1341	no
T49	PROC 1342 1349	tratada
T50	Negated 1342 1349	tratada
T51	DISO 1361 1385	enfermedad leptomeníngea
T52	DISO 1388 1406	compresión medular
#17	AnnotatorNotes T52	C0037926; Compression of spinal cord; Disease or Syndrome
T53	LIVB 1409 1422	Participantes
T54	DISO 1427 1434	ascitis
#18	AnnotatorNotes T54	C0003962; Ascites; Disease or Syndrome
T55	Neg_cue 1439 1441	no
T56	Negated 1451 1460	controlar
T57	PROC 1465 1479	intervenciones
#19	AnnotatorNotes T57	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T58	DISO 1494 1518	Enfermedades infecciosas
#20	AnnotatorNotes T58	C0009450; Communicable Diseases; Disease or Syndrome
T59	DISO 1533 1545	tuberculosis
#21	AnnotatorNotes T59	C0041296; Tuberculosis; Disease or Syndrome | C0041327; Tuberculosis, Pulmonary; Disease or Syndrome
T60	DISO 1547 1564	infección por VIH
#22	AnnotatorNotes T60	C0019693; HIV Infections; Disease or Syndrome
T61	DISO 1567 1582	hepatitis A/B/C
T62	DISO 1586 1610	Enfermedad intercurrente
#23	AnnotatorNotes T62	C0277557; Intercurrent disease; Disease or Syndrome
T63	Neg_cue 1611 1613	no
T64	Negated 1614 1624	controlada
T65	DISO 1628 1666	Trastornos autoinmunes o inflamatorios
T66	PROC 1716 1737	tratamiento sistémico
T67	Route 1728 1737	sistémico
T68	CHEM 1742 1752	esteroides
#24	AnnotatorNotes T68	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T69	PROC 1760 1786	tratamiento inmunosupresor
T70	DISO 1811 1837	neoplasia maligna primaria
#25	AnnotatorNotes T70	C1306459; Primary malignant neoplasm; Neoplastic Process
T71	PROC 1841 1852	Tratamiento
#26	AnnotatorNotes T71	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T72	CHEM 1867 1891	agente inmuno-oncológico
